Literature DB >> 8968863

Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas.

M M Song1, Y Nio, Y Sato, K Tamura, K Furuse.   

Abstract

CONCLUSION: The present study suggests that Ki-ras point mutations may play an important role in the early stages of tumorigenesis and that a double mutation has a stronger detrimental effect than a single mutation on the survival after pancreatectomy.
BACKGROUND: Previous studies have suggested the important role of Ki-ras point mutations in ras gene codon 12 in the tumorigenesis of pancreatic cancer, but their clinicopathological significance is still unclear. The present study was designed to assess the clinicopathological significance of Ki-ras point mutations, and p21 expression in malignant and benign diseases of the pancreas.
METHODS: Oligonucleotide dot-blot hybridization for Ki-ras point mutations in codon 12 and immunohistochemical staining for p21 expression were applied. Cases included 44 primary and 15 metastatic lesions of pancreatic cancer, and 17 benign pancreatic diseases.
RESULTS: Ki-ras point mutations and p21 expression were detected in 43 and 19 primary lesions, 9 and 6 metastatic lesions, and four and five benign diseases, respectively. The patients with a single mutation had a better survival after pancreatectomy than those with a double mutation. The patients with a p21(+) GAT mutation showed the worst survival after pancreatectomy compared with other categories of patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968863     DOI: 10.1007/bf02825506

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  30 in total

1.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.

Authors:  S E Goelz; S R Hamilton; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1985-07-16       Impact factor: 3.575

2.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

3.  Molecular genetic profiles of colitis-associated neoplasms.

Authors:  S E Kern; M Redston; A B Seymour; C Caldas; S M Powell; S Kornacki; K W Kinzler
Journal:  Gastroenterology       Date:  1994-08       Impact factor: 22.682

4.  Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.

Authors:  M Tada; M Omata; S Kawai; H Saisho; M Ohto; R K Saiki; J J Sninsky
Journal:  Cancer Res       Date:  1993-06-01       Impact factor: 12.701

5.  K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis.

Authors:  M Imai; T Hoshi; K Ogawa
Journal:  Cancer       Date:  1994-06-01       Impact factor: 6.860

6.  Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation.

Authors:  A Yanagisawa; K Ohtake; K Ohashi; M Hori; T Kitagawa; H Sugano; Y Kato
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

7.  Pancreatic cancer in Europe: Ki-ras gene mutation pattern shows geographical differences.

Authors:  A Scarpa; P Capelli; A Villaneuva; G Zamboni; F Lluìs; R Accolla; G Mariuzzi; G Capellà
Journal:  Int J Cancer       Date:  1994-04-15       Impact factor: 7.396

8.  High frequency of K-ras mutations in sporadic colorectal adenomas.

Authors:  E A McLellan; R A Owen; K A Stepniewska; J P Sheffield; N R Lemoine
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

9.  Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer.

Authors:  H Iguchi; K Sugano; N Fukayama; H Ohkura; K Sadamoto; K Ohkoshi; Y Seo; H Tomoda; A Funakoshi; H Wakasugi
Journal:  Gastroenterology       Date:  1996-01       Impact factor: 22.682

10.  Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma.

Authors:  G C Burmer; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more
  3 in total

1.  Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.

Authors:  Matthias Löhr; Günter Klöppel; Patrick Maisonneuve; Albert B Lowenfels; Jutta Lüttges
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

2.  Comparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses.

Authors:  N T van Heek; S J Clayton; P D J Sturm; J Walker; D J Gouma; L A Noorduyn; G J A Offerhaus; J C Fox
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

3.  High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.

Authors:  Michael Krypuy; Genni M Newnham; David M Thomas; Matthew Conron; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2006-12-21       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.